Insights

Bio Endeavors, August 2022: Harnessing evolution

August 2, 2022

Climate tech is here to stay

July 12, 2022

Introducing Bio Endeavors: A newsletter for Bio X Tech

June 23, 2022

29 VC firms still funding electric car, battery, and charging startups as the economy darkens

June 23, 2022

An Unconference like no other

June 15, 2022

Operational machine learning for the modern data stack

June 7, 2022

Innovation Endeavors is growing: introducing Carrie and Casey

May 18, 2022

Developer-first secure computation

May 17, 2022

Deep real-world drug discovery — our investment in Character Biosciences

May 17, 2022

The experimentation model works because of 4 processes

May 3, 2022

Transforming mining for the better

March 21, 2022

We have a new operating partner

March 3, 2022

A new dawn in drug discovery — why we tripled down on Eikon Therapeutics

January 5, 2022

Rising above the noise — why we doubled down on Anyword

November 17, 2021

Making automated, flexible manufacturing a reality with robotics

November 16, 2021

Learn about what is happening in our universe

Bio Endeavors, August 2022: Harnessing evolution

Bio Endeavors, August 2022: Harnessing evolution

Climate tech is here to stay

Climate tech is here to stay

Introducing Bio Endeavors: A newsletter for Bio X Tech

Introducing Bio Endeavors: A newsletter for Bio X Tech

29 VC firms still funding electric car, battery, and charging startups as the economy darkens

29 VC firms still funding electric car, battery, and charging startups as the economy darkens

An Unconference like no other

An Unconference like no other

Operational machine learning for the modern data stack

Operational machine learning for the modern data stack

Innovation Endeavors is growing: introducing Carrie and Casey

Innovation Endeavors is growing: introducing Carrie and Casey

Developer-first secure computation

Developer-first secure computation

Deep real-world drug discovery — our investment in Character Biosciences

Deep real-world drug discovery — our investment in Character Biosciences

The experimentation model works because of 4 processes

The experimentation model works because of 4 processes

Transforming mining for the better

Transforming mining for the better

We have a new operating partner

We have a new operating partner

A new dawn in drug discovery — why we tripled down on Eikon Therapeutics

A new dawn in drug discovery — why we tripled down on Eikon Therapeutics

Rising above the noise — why we doubled down on Anyword

Rising above the noise — why we doubled down on Anyword

Making automated, flexible manufacturing a reality with robotics

Making automated, flexible manufacturing a reality with robotics

Stay up to date

Navigate

Learn about what is happening in our universe

Bio Endeavors, August 2022: Harnessing evolution

Bio Endeavors, August 2022: Harnessing evolution

Climate tech is here to stay

Climate tech is here to stay

Introducing Bio Endeavors: A newsletter for Bio X Tech

Introducing Bio Endeavors: A newsletter for Bio X Tech

29 VC firms still funding electric car, battery, and charging startups as the economy darkens

29 VC firms still funding electric car, battery, and charging startups as the economy darkens

An Unconference like no other

An Unconference like no other

Operational machine learning for the modern data stack

Operational machine learning for the modern data stack

Innovation Endeavors is growing: introducing Carrie and Casey

Innovation Endeavors is growing: introducing Carrie and Casey

Developer-first secure computation

Developer-first secure computation

Deep real-world drug discovery — our investment in Character Biosciences

Deep real-world drug discovery — our investment in Character Biosciences

The experimentation model works because of 4 processes

The experimentation model works because of 4 processes

Transforming mining for the better

Transforming mining for the better

We have a new operating partner

We have a new operating partner

A new dawn in drug discovery — why we tripled down on Eikon Therapeutics

A new dawn in drug discovery — why we tripled down on Eikon Therapeutics

Rising above the noise — why we doubled down on Anyword

Rising above the noise — why we doubled down on Anyword

Making automated, flexible manufacturing a reality with robotics

Making automated, flexible manufacturing a reality with robotics

Stay up to date

Navigate

Follow Us